by University of Birmingham A new study led by scientists at the University of Birmingham has shed fresh light on how a key front-line drug kills the tuberculosis bacterium. The research paves the way for development of new antibiotic drugs targeted at emerging strains of TB. Tuberculosis (TB) remains a global health challenge, responsible for...
By Ana Sandoiu Fact checked by Jasmin Collier As the homeopathic industry grows, the Food and Drug Administration (FDA) issue a statement to present two major steps they are taking to protect the public from the potentially harmful effects of products labeled as “homeopathic.” According to some estimates, a third of adults and more than...
An alder bark may become a great source of anti-aging and anti-disease natural antioxidants IMMANUEL KANT BALTIC FEDERAL UNIVERSITY An alder bark may become a great source of anti-aging and anti-disease natural antioxidants. That’s the results discovered by the IKBFU’s Institute of Living Systems researchers. For the past 10 years, the workers of the IKBFU’s...
In the war on antibiotic-resistant bacteria, it’s not just the antibiotics that are making the enemy stronger but also how they are prescribed. A new study suggests that doctors can beat antibiotic resistance using those same antibiotics but in a very targeted manner and in combination with other health strategies. The current broad application of antibiotics helps resistant bacterial strains evolve forward. But using data about...
Birch has anti-bacterial and anti-inflammatory properties, expert says Gel using birch sped up healing in 86% of people compared to standard gel The product is being developed by experts who say there is a gap in treatment A chemical found in birch bark helps wounds heal faster and with less scarring than ordinary creams, researchers say. Tests on a gel, which contains betulin,...
Scientists have taken a key step towards improving an emerging class of treatments for Parkinson’s disease. The advance could markedly improve a next generation of therapies for the condition, which affects around one in 350 people in the UK. It could aid development of the promising treatment – known as cell replacement therapy – which...
